Sandostatin.com has medical information about Sandostatin diarrhea treatment

Title

Sandostatin.com Global for Healthcare Professionals - Sandostatin LAR Home

Description

medical therapy in the treatment of acromegaly and symptoms of gastro-entero-pancreatic neuroendocrine (GEP NE) tumours. Sandostatin® LAR® maintains all of the clinical and pharmacological characteristics of the immediate-release dosage form of subcutaneous (SC) Sandostatin® (octreotide acetate) Injection, with the added feature of convenient, once-monthly administration. Sandostatin® LAR® has a well-tolerated safety profile backed by more than a decade of clinical use.

In the majority of patients, Acromegaly Sandostatin® LAR® controls growth hormone (GH) and insulin-like growth factor I (IGF-I) and reduces the size of tumours to help control symptoms of acromegaly.

In the majority of patients, Sandostatin® LAR® controls gastrointestinal hormone secretion to help reduce diarrhoea and flushing and suppress 5- hydroxyindoleacetic acid (5-HIAA) in patients with GEP NE tumours and carcinoid syndrome.

read more

Languages

English

Additional Information

Related Domains



Retrieved from "http://aboutus.com/index.php?title=Sandostatin.com&oldid=36442051"